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THIS study describes the clinical profile of tacrolimus (Tac) nephrotoxicity after renal transplantation. Tac 
was given initially as a 0,075 to 0.1 mg/kg/day IV continuous 
infusion and then orally at 0.15 mglkg twice daily. Patients 
were selected based on a rising serum creatinine. normal 
ultrasound, and absence of rejection on biopsy, leading to a 
reduction in Tac dosage and fall in creatinine. Twenty-two 
(17%) cases of nephrotoxicity were identified among 128 
kidney transplant biopsies. This compares with a OMKR<g~ 
incidence reported by the Japanese FK506 study group.! 
The onset of nephrotoxicity occurred 1 to 156 weeks 
postoperatively. The mean baseline creatinine was 2.4 ::': 1.9 
mg/dL (range 1.0 to 9.9) and rose 40.6% ::': 14.2% (range 11 
to 66) during episodes of nephrotoxicity. Mean peak plasma 
(n = 10) and whole blood (n = 12) Tac levels during the 
toxic episodes were. respectively, 2.7 ::': 0.8 ng/mL (range 
1.1 to 3.5) and 31.6 ::': 10.6 ng/mL (range 14.5 to 50.5). The 
drug levels were considered to be beyond the therapeutic 
range in 18 of 22 (82%) patients. The highest Tae level 
preeeeded the rise in creatinine in 20 cases by 1.6 ::': 1.8 
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days. A mean reduction in Tac dosage of 41 Sf ::': 21 c; 
(range 11 to 89) led to a 86'1f ::': 18'1( (range 45 to 1(0) fall 
in serum creatinine in 1 to 14 days. Serum potassium higher 
than 5.0 mEq/L was recorded in 9 of 22 (41 %) cases. More 
than three elevations in blood glucose greater than 140 
mg/dL were recorded in 4 of II (36%) non-diabetic pa-
tients. Hand tremors were seen in two (9%) cases and 
elevated diastolic blood pressure higher than 90 mm Hg in 
seven (32%) patients. 
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